RxDoctor Payments Data

Susan Chambers, MD

Obstetrics & Gynecology · Oklahoma City, OKNPI 1881613701

Payments from drug & device makers

$2,753in general payments, 2019–2025

Across 153 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$647
  • Organon$405
  • Mayne Pharma Commercial LLC$290
  • Bayer$193
  • Astellas Pharma US Inc$171
  • Hologic Sales And Service, LLC$151
  • plus $896 from 21 others

What the payments were for

  • Food & beverage$2,64296%
  • Education$1114%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,753 in reported general payments places this provider in the 65th percentile of 396 obstetrics & gynecology providers in Oklahoma.

See all obstetrics & gynecology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$34,201
Medicare patients
277
Services billed
911

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron13$14,164
Estradiol153$3,633
Estradiol (Twice Weekly)Estradiol34$3,524
ProgesteroneProgesterone, Micronized75$3,436
DottiEstradiol20$1,573
Raloxifene Hcl16$1,331
Clobetasol Propionate42$1,027
ValacyclovirValacyclovir Hcl17$509
Escitalopram Oxalate22$440
Levothyroxine Sodium37$431
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst27$387
Oxybutynin Chloride ErOxybutynin Chloride12$228
Acyclovir11$226
Fluconazole26$128
Cephalexin14$81

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$171$14,16413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 396 obstetrics & gynecology providers in Oklahoma.

Other obstetrics & gynecology in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →